| Schedule of profit or loss and total assets for each reportable segment |
Nine Months Ended May 31, 2024 |
|
IP Licensing |
|
|
B2B Product |
|
|
R&D |
|
|
Corporate |
|
|
Consolidated Total |
|
Revenue |
|
$ |
373,990 |
|
|
$ |
5,388 |
|
|
$ |
900 |
|
|
$ |
- |
|
|
$ |
380,278 |
|
Cost of goods sold |
|
|
- |
|
|
|
(4,822 |
) |
|
|
- |
|
|
|
- |
|
|
|
(4,822 |
) |
Operating expenses |
|
|
(130 |
) |
|
|
(288 |
) |
|
|
(1,393,359 |
) |
|
|
(2,531,745 |
) |
|
|
(3,925,522 |
) |
Other Income(Expense) |
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
(72,017 |
) |
|
|
(72,017 |
) |
Segment Income (Loss) |
|
$ |
373,860 |
|
|
$ |
278 |
|
|
$ |
(1,392,459 |
) |
|
$ |
(2,603,762 |
) |
|
$ |
(3,622,083 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets |
|
$ |
124,968 |
|
|
$ |
63,573 |
|
|
$ |
475,194 |
|
|
$ |
9,354,702 |
|
|
$ |
10,018,437 |
|
Nine Months Ended May 31, 2023 |
|
IP Licensing |
|
|
B2B Product |
|
|
R&D |
|
|
Corporate |
|
|
Consolidated Total |
|
Revenue |
|
$ |
104,935 |
|
|
$ |
44,167 |
|
|
$ |
46,365 |
|
|
$ |
- |
|
|
$ |
195,467 |
|
Cost of goods sold |
|
|
- |
|
|
|
(31,500 |
) |
|
|
- |
|
|
|
- |
|
|
|
(31,500 |
) |
Operating expenses |
|
|
(58,845 |
) |
|
|
(235,379 |
) |
|
|
(3,166,315 |
) |
|
|
(2,123,337 |
) |
|
|
(5,583,876 |
) |
Other Income (Expense) |
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
(43,601 |
) |
|
|
(43,601 |
) |
Segment Income (Loss) |
|
$ |
46,090 |
|
|
$ |
(222,712 |
) |
|
$ |
(3,119,950 |
) |
|
$ |
(2,166,938 |
) |
|
$ |
(5,463,510 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets |
|
$ |
110,997 |
|
|
$ |
67,705 |
|
|
$ |
538,571 |
|
|
$ |
4,522,364 |
|
|
$ |
5,239,637 |
|
|